Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques

Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

RT @NatureNews: Flu virus finally sequenced in its native RNA form for the first time
h J R
Stephen Angeloni, PhD, Sr Field Applications Scientist, will be at #Immunology2018 to help with your assay optimiza…
h J R
RT @CDCFlu: CDC estimates that #fluvax during the 2016–2017 flu season prevented an estimated 5.3 million illnesses, 2.6 million medical vi…
h J R

Latest News

March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

January 24
Luminex Corporation Declares First Quarter Cash Dividend

January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017


AACR Annual Meeting
April 14-18
Chicago, IL

April 12-14
Helena, MT

April 18-20
Naperville, IL

April 21-24
Madrid, Spain

Immunology 2018
May 4-8
Austin, TX